HPC Biosciences Ltd (HPBC)

Currency in INR
25.68
0.00(0.00%)
Closed·

HPBC Financial Summary

Key Ratios

P/E Ratio0
Price/Book0
Debt / Equity0%
Return on Equity0.07%
Dividend Yield0.00%
EBITDA-207.00K
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2014
31/03
2015
31/03
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
* In Millions of INR (except for per share items)

Earnings

Latest Release
Sep 28, 2023
EPS / Forecast
-- / --
Revenue / Forecast
1.09M / --
EPS Revisions
Last 90 days

FAQ

What was HPC Biosciences Ltd's net income for the latest quarter?

HPC Biosciences Ltd's net income for the latest quarter was 0.70.

How did HPC Biosciences Ltd's performance compare year-over-year in the latest quarter?

The company's revenue moved from 1.03 in the previous quarter to 1.09 in the latest quarter, and net income moved from -0.49 to 0.70 compared to the previous quarter.

What is HPC Biosciences Ltd's net profit margin on a TTM basis?

HPC Biosciences Ltd's trailing twelve months (TTM) net profit margin is 9.99%.

How does HPC Biosciences Ltd's debt to equity ratio compare to industry standards?

HPC Biosciences Ltd's total debt-to-equity ratio is 0.00%.

What is HPC Biosciences Ltd's return on investment on a TTM basis?

HPC Biosciences Ltd's trailing twelve months (TTM) return on investment (ROI) is 0.07%.

Did HPC Biosciences Ltd gain or lose cash last quarter?

In the latest quarter, HPC Biosciences Ltd's net change in cash was -1.89 million.

What were HPC Biosciences Ltd's total assets and liabilities in the latest quarter?

As of the latest quarter, HPC Biosciences Ltd reported total assets of 321.83 million and total liabilities of 2.63 million.

How has HPC Biosciences Ltd's total revenue grown this year?

HPC Biosciences Ltd's total revenue was 1.03 in the previous quarter and 1.09 in the latest quarter.

What was HPC Biosciences Ltd's revenue per share for the latest quarter?

HPC Biosciences Ltd's revenue per share for the latest quarter was 276.49.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.